Mounjaro (tirzepatide) - Eli Lilly
Zepbound (tirzepatide) - Eli Lilly
Dupixent (dupilumab) - Sanofi, Regeneron
Precision Medicine in Overlap Syndrome (COPD-Obstructive Sleep Apnea): From Phenotypes and Endotypes to Treatable Traits. (PubMed, Adv Respir Med) - Sep 24, 2026 - "Endotyping of OVS may provide a framework for moving beyond a uniform therapeutic approach toward more individualized management based on the dominant underlying biological mechanism. Randomized clinical trials focusing on endotypic stratification and OVS cohorts remain research priorities." 
Biomarker • Clinical • Journal • Review • Cardiovascular • Chronic Obstructive Pulmonary Disease • Genetic Disorders • Immunology • Inflammation • Obesity • Obstructive Sleep Apnea • Pulmonary Disease • Respiratory Diseases • Sleep Disorder
http://www.ncbi.nlm.nih.gov/pubmed/42776697
 
Adriana Loredana Pintilie; Andreea Zabara Antal; Carina Adina Afloarei; David Toma; Georgiana Pitusac; Radu Crisan Dabija; Raluca Tiron; Teodor Zaharia; Tudor Birladeanu
 
Sep 24, 2026
 
Prev Next